Log in
Donate
Search
Close this search box.

Clinical Trial: ECOG-ACRIN EAY191-A3

ECOG-ACRIN EAY191-A3

Status: Open

NCT#05554367

Palbociclib and Binimetinib in RAS-Mutant Cancers: A ComboMATCH Treatment Trial
(See required screening study ECOG-ACRIN EAY191)

EAY191-A3, Cohort 3 is temporarily closed to accrual effective July 3, 2024.

EAY191-A3, Cohort 4 is temporarily closed to accrual effective July 8, 2024.

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved